Coherus Oncology (CHRS) Operating Income Growth (5y) (2018 - 2026)
Coherus Oncology (CHRS) Operating Income Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,930.48 Bn | 1,930.42 Bn | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - |
| 4 | BeOne Medicines | 468.55 Bn | 463.76 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.04 Bn | 115.79 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.31 Bn | 61.56 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.40 Bn | 63.40 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn |
| 10 | Coherus Oncology | 198.46 Mn | 31.41 Mn | 8.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.40% |
| Dec 31, 2025 | -36.81% |
| Sep 30, 2025 | -27.08% |
| Jun 30, 2025 | -21.94% |
| Mar 31, 2025 | -25.49% |
| Dec 31, 2024 | -24.64% |
| Sep 30, 2024 | -23.76% |
| Jun 30, 2024 | -28.04% |
| Mar 31, 2024 | -32.50% |
| Dec 31, 2023 | -2.64% |
| Sep 30, 2023 | 10.89% |
| Jun 30, 2023 | 5.11% |
| Mar 31, 2023 | -10.02% |
| Dec 31, 2022 | -2.08% |
| Sep 30, 2022 | -7.28% |
| Jun 30, 2022 | 4.92% |
| Mar 31, 2022 | -2.25% |
| Dec 31, 2021 | 11.65% |
| Sep 30, 2021 | -19.01% |
| Jun 30, 2021 | 17.37% |